Authors/Disclosures
|
Giuseppe Bomboi, MD
(Neuroimmunology Branch, NINDS/NIH)
|
No disclosure on file |
|
Vasiliki N. Ikonomidou
(NINDS/NIH)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Antonio G. Gallo, MD
|
No disclosure on file |
|
Iordanis Evangelou
(Children'S National Medical Center)
|
No disclosure on file |
|
|
No disclosure on file |
|
Joan M. Ohayon
(National Institutes of Health)
|
Joan M. Ohayon has nothing to disclose. |
|
Fredric K. Cantor, MD, FAAN
(National Institute of Neurological Disease & Stroke)
|
No disclosure on file |
|
|
No disclosure on file |
|
Robert Kane, PhD, ABPP-CN
(Cognitive Consults and Technology LLC)
|
No disclosure on file |
|
Henry F. McFarland, MD
(Clinical Neuroscience Consulting)
|
Dr. McFarland has received intellectual property interests from a discovery or technology relating to health care. Dr. McFarland has received personal compensation in the range of $50,000-$99,999 for serving as a Medical Director with Cumming Foundation. |
|
Francesca Bagnato, MD
(Vanderbilt University Medical Center)
|
Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono. |